Trailing-twelve-month (TTM) revenue is $4.67 Billion with a year-over-year growth of +0.41%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-10-31 | $1,155,030,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-24 |
| Q2 FY2026Period ended 2026-01-31 | $1,121,674,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-03 |
| Q3 FY2026Period ended 2026-04-30 | $1,237,066,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-29 |
| Q4 FY2026Period ended 2026-07-31 | $1,152,439,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-10 |
| TTM revenue | $4,666,209,000 |
Current P/S: $29,375,998,324 market capitalization ÷ $4,666,209,000 TTM revenue = 6.30x.
Market capitalization source: FMP quote. Quote observed 2026-09-14T20:00:01.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-07-31): $1.15B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T08:30:20.257Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-07-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-07-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-07-31 · USD | FY20212021-07-31 · USD | FY20222022-07-31 · USD | FY20232023-07-31 · USD | FY20242024-07-31 · USD | FY20252025-07-31 · USD |
|---|---|---|---|---|---|---|
| Product | $258M | $401M | $648M | $671M | $676M | $678M |
| Service | $1.9B | $2.3B | $2.9B | $3.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-07-31 · USD | FY20212021-07-31 · USD | FY20222022-07-31 · USD | FY20232023-07-31 · USD | FY20242024-07-31 · USD | FY20252025-07-31 · USD |
|---|---|---|---|---|---|---|
| International | $345M | $420M | $556M | $680M | $772M | $792M |
| UNITED STATES | $1.9B | $2.3B | $2.9B | $3.2B |
$4.67B
$4.67 Billion
+0.41%
vs. $4.65B a year ago (TTM)
+11.63%
5 Year compound annual growth rate
1 Year
+0.41%
3 Year
+6.44%
5 Year
+11.63%
10 Year
+13.91%
15 Year
+11.83%
20 Year
+11.48%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $4.67B | +$19.25M | +0.41% |
| 2025 | $4.65B | +$410.13M | +9.68% |
| 2024 | $4.24B | +$367.31M | +9.49% |
| 2023 | $3.87B | +$368.60M | +10.53% |
| 2022 | $3.50B | +$808.41M | +30.02% |
| 2021 |
TTM Growth
+0.41%
3-Year CAGR
+6.44%
5-Year CAGR
+11.63%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-15T08:30:20.257Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $3.6B |
| $4.0B |
| $3.5B |
| $3.9B |
| $2.69B |
| +$486.93M |
| +22.08% |
| 2020 | $2.21B | +$163.63M | +8.01% |
| 2019 | $2.04B | +$236.26M | +13.08% |
| 2018 | $1.81B | +$357.71M | +24.70% |
| 2017 | $1.45B | +$179.53M | +14.15% |
